Stifel analyst Jonathan Block said Medtronic’s 4QF18 Diabetes division results are encouraging for Intricon Corp (NASDAQ: IIN).Block highlights that diabetes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE